#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15842	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2455	793.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1629	1629	C	1014	C,T,G,A	1011,1,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15842	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2455	793.8	0	HET	.	.	.	C611T	.	611	611	C	1056	1056	C	978	C,T	769,208	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26598	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3940	841.2	0	.	n	.	0	T695C	SNP	695	695	T	1206	1206	C	958	C,T,A	955,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26598	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3940	841.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1848	1848	A	1115	A,C	1113,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26598	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3940	841.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2482	2482	C	960	C,G,A	958,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26598	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3940	841.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3108	3108	T	937	T,G	936,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26598	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3940	841.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2556	2556	A	881	A,C	877,3	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2496	folP	852	852	100.0	folP.l15.c4.ctg.1	2128	146.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1238	1240	AGC	264;265;263	A;G;C	264;265;263	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6220	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3950	196.3	1	SNP	p	S91F	0	.	.	271	273	TCC	768	770	TCC	236;233;235	T;C,A;C,A	236;232,1;234,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6220	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3950	196.3	1	SNP	p	D95N	0	.	.	283	285	GAC	780	782	GAC	238;240;239	G;A;C	238;240;239	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6220	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3950	196.3	1	SNP	p	D95G	0	.	.	283	285	GAC	780	782	GAC	238;240;239	G;A;C	238;240;239	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	2346	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1811	161.3	1	SNP	p	G45D	1	.	.	133	135	GAC	672	674	GAC	278;278;276	G;A,C;C,A	278;277,1;275,1	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1280	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1497	106.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5574	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3449	201.6	1	SNP	p	D86N	0	.	.	256	258	GAC	837	839	GAC	239;240;238	G;A,C;C	239;239,1;238	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5574	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3449	201.6	1	SNP	p	S87R	0	.	.	259	261	AGT	840	842	AGT	238;239;241	A;G,T;T,G,C	238;238,1;239,1,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5574	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3449	201.6	1	SNP	p	S87W	0	.	.	259	261	AGT	840	842	AGT	238;239;241	A;G,T;T,G,C	238;238,1;239,1,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5574	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3449	201.6	1	SNP	p	S87I	0	.	.	259	261	AGT	840	842	AGT	238;239;241	A;G,T;T,G,C	238;238,1;239,1,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5574	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3449	201.6	1	SNP	p	S88P	0	.	.	262	264	TCC	843	845	TCC	242;244;246	T;C;C	242;244;246	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4888	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3112	195.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1729	1731	GGC	271;267;268	G,T;G,A;C,T	270,1;265,1;266,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1476	1478	GCA	295;299;301	G;C;A,C	295;299;300,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1479	1481	ATC	296;292;292	A;T;C,A	296;292;291,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1491	1493	GTG	305;304;307	G,T,A;T,G;G	302,2,1;303,1;307	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1491	1493	GTG	305;304;307	G,T,A;T,G;G	302,2,1;303,1;307	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1995	1997	ACC	273;272;273	A,C;C;C,G	272,1;272;272,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2049	2051	GCG	256;258;261	G,T;C;G	255,1;258;261	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2049	2051	GCG	256;258;261	G,T;C;G	255,1;258;261	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2172	2174	GGC	231;236;235	G;G,T;C,A	231;235,1;234,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2181	2183	GGC	232;234;234	G,A;G;C	231,1;234;234	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4502	penA	1749	1749	100.0	penA.l15.c30.ctg.1	3005	186.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2199	2201	CCG	233;239;236	C,G;C;G,A,T,C	232,1;239;233,1,1,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5916	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3596	205.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1881	1883	CTG	243;243;240	C,A;T,C;G,A	242,1;242,1;239,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3098	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2254	171.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	821	821	C	253	C	253	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2882	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1646	212.0	0	.	p	.	0	I45V	NONSYN	133	135	ATT	598	600	GTT	249;248;247	G,T;T,G;T,A	248,1;247,1;246,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2882	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1646	212.0	0	.	p	.	0	N121S	NONSYN	361	363	AAC	826	828	AGC	246;248;244	A;G;C	246;248;244	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2882	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1646	212.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	829	831	AAA	247;244;245	A;A;A,T	247;244;244,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2882	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1646	212.0	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	892	894	GAA	255;257;258	G;A;A,T,G,C	255;257;255,1,1,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2882	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1646	212.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	916	918	GCA	255;252;249	G,A;C;A	254,1;252;249	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2882	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1646	212.0	0	.	p	.	0	K207_M208insK	INS	619	619	A	1084	1084	A	281	A	281	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2882	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1646	212.0	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1102	1104	TCA	274;274;278	T,C;C,A;A	273,1;273,1;278	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2882	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1646	212.0	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1219	1219	T	218	T,C	217,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	268	porB3	990	162	93.83	porB3.l15.c30.ctg.1	163	60.6	0	.	p	.	0	S273T	NONSYN	817	819	TCG	61	63	ACT	79;79;79	A;C;T	79;79;79	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	268	porB3	990	162	93.83	porB3.l15.c30.ctg.1	163	60.6	0	.	p	.	0	D276S	NONSYN	826	828	GAT	70	72	AGT	79;79;79	A;G;T	79;79;79	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	268	porB3	990	162	93.83	porB3.l15.c30.ctg.1	163	60.6	0	.	p	.	0	K278D	NONSYN	832	834	AAA	76	78	GAC	79;79;79	G;A;C	79;79;79	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	268	porB3	990	162	93.83	porB3.l15.c30.ctg.1	163	60.6	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	79	81	TAC	79;79;79	T;A;C	79;79;79	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10154	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5282	239.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2200	2202	AAT	271;269;269	A,C;A,G;T,C	270,1;267,2;268,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1504	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1459	128.4	1	SNP	p	V57M	1	.	.	169	171	ATG	749	751	ATG	232;238;235	A;T,G;G	232;237,1;235	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
